What is Spencer Pharmaceutical Inc?
develops drug platform technologies for the treatment of neurological deceases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
develops drug platform technologies for the treatment of neurological deceases. The company specializes in the controlled release of existing therapeutic molecules in the areas of central nervous system, which include Alzheimer and Parkinson diseases, and brain cancer; and patented slow release drug delivery technology for the treatment of type-2 diabetes, arthritis, and other potential applications. The company is listed on the OTCCE in USA, operating in the Healthcare sector, with a market capitalisation of 1.34M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.